PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany. maria-margarete.karsten@charite.de.\', \'Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.\', \'Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'OnkoZert GmbH, Neu-Ulm, Germany.\', \'Deutsche Krebsgesellschaft e.V., Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05642-6
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34583744
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all